Protelos Demonstrates Unique Long Term Osteoporotic Fracture Reduction

The results of two landmark studies announced today at the Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO), confirms the evidence based, long-term efficacy of Protelos (strontium ranelate) for the reduction of nonvertebral and vertebral osteoporotic fractures over five years. This is the first time an anti-osteoporotic treatment has demonstrated fracture reduction efficacy after five years of treatment.

Recent Blog Post

Study Reveals Higher BMI Puts Adolescents at Risk for Depression 

5th September 2023 – By King’s College London Children between the ages of 12 and 16 with a higher body...

Diversity at TwinsUK: Genevieve

Genevieve joined the department in 2010 and has since gained an extensive knowledge of the TwinsUK data. She is responsible...

Diversity at TwinsUK: Bridget

Bridget is one of our Clinical Research Nurses, part of the clinic team who you’ll see when coming to St...